Equities analysts expect Procter & Gamble Company (The) (NYSE:PG) to post earnings per share (EPS) of $1.07 for the current quarter, according to Zacks. Eight analysts have provided estimates for Procter & Gamble Company (The)’s earnings, with estimates ranging from $1.04 to $1.09. Procter & Gamble Company (The) reported earnings per share of $1.03 in the same quarter last year, which suggests a positive year over year growth rate of 3.9%. The company is scheduled to issue its next earnings report on Tuesday, October 24th.

According to Zacks, analysts expect that Procter & Gamble Company (The) will report full year earnings of $4.17 per share for the current year, with EPS estimates ranging from $4.15 to $4.20. For the next fiscal year, analysts anticipate that the firm will post earnings of $4.44 per share, with EPS estimates ranging from $4.39 to $4.50. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Procter & Gamble Company (The).

Procter & Gamble Company (The) (NYSE:PG) last posted its earnings results on Thursday, July 27th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.07. The company had revenue of $16.08 billion for the quarter, compared to analysts’ expectations of $16.01 billion. Procter & Gamble Company (The) had a return on equity of 19.52% and a net margin of 23.56%. Procter & Gamble Company (The)’s quarterly revenue was down .1% on a year-over-year basis. During the same period last year, the firm earned $0.79 earnings per share.

PG has been the topic of a number of research analyst reports. Vetr upgraded shares of Procter & Gamble Company (The) from a “hold” rating to a “buy” rating and set a $94.67 target price on the stock in a research note on Wednesday, April 26th. Jefferies Group LLC restated a “buy” rating and issued a $103.00 target price on shares of Procter & Gamble Company (The) in a research note on Wednesday, April 26th. Stifel Nicolaus dropped their target price on shares of Procter & Gamble Company (The) from $88.00 to $87.00 and set a “hold” rating on the stock in a research note on Thursday, April 27th. Zacks Investment Research upgraded shares of Procter & Gamble Company (The) from a “sell” rating to a “hold” rating in a research note on Wednesday, April 12th. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $80.00 target price on shares of Procter & Gamble Company (The) in a research note on Monday, April 24th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $88.21.

ILLEGAL ACTIVITY NOTICE: This piece was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/08/zacks-analysts-anticipate-procter-gamble-company-the-pg-to-announce-1-07-eps.html.

Shares of Procter & Gamble Company (PG) opened at 91.44 on Tuesday. The stock has a market capitalization of $233.47 billion, a price-to-earnings ratio of 16.35 and a beta of 0.68. Procter & Gamble Company has a one year low of $81.18 and a one year high of $92.00. The firm has a 50-day moving average of $88.56 and a 200 day moving average of $88.68. Procter & Gamble Company (The) also saw some unusual options trading activity on Monday. Stock investors bought 35,861 call options on the stock. This represents an increase of 509% compared to the typical daily volume of 5,886 call options.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Friday, July 21st will be given a dividend of $0.6896 per share. The ex-dividend date is Wednesday, July 19th. This represents a $2.76 dividend on an annualized basis and a yield of 3.02%. Procter & Gamble Company (The)’s payout ratio is 49.37%.

In related news, insider Suranjan Magesvaran sold 10,512 shares of the stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $91.00, for a total transaction of $956,592.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Patrice Louvet sold 48,310 shares of the stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $86.79, for a total transaction of $4,192,824.90. Following the sale, the insider now directly owns 95,340 shares of the company’s stock, valued at approximately $8,274,558.60. The disclosure for this sale can be found here. Insiders have sold 203,898 shares of company stock valued at $17,666,387 in the last three months. 0.35% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the stock. Integrated Investment Consultants LLC boosted its stake in Procter & Gamble Company (The) by 1.1% in the first quarter. Integrated Investment Consultants LLC now owns 14,017 shares of the company’s stock worth $1,259,000 after buying an additional 150 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Procter & Gamble Company (The) by 2.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 417,703 shares of the company’s stock worth $35,128,000 after buying an additional 9,273 shares during the last quarter. Lincluden Management Ltd. boosted its position in Procter & Gamble Company (The) by 8.0% in the fourth quarter. Lincluden Management Ltd. now owns 119,056 shares of the company’s stock worth $10,010,000 after buying an additional 8,822 shares in the last quarter. Cigna Investments Inc. New bought a new position in Procter & Gamble Company (The) during the fourth quarter worth about $8,507,000. Finally, Hefty Wealth Partners boosted its position in Procter & Gamble Company (The) by 1,730.0% in the first quarter. Hefty Wealth Partners now owns 11,730 shares of the company’s stock worth $1,053,000 after buying an additional 11,089 shares in the last quarter. 59.69% of the stock is owned by institutional investors.

Procter & Gamble Company (The) Company Profile

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Get a free copy of the Zacks research report on Procter & Gamble Company (The) (PG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Procter & Gamble Company (The) (NYSE:PG)

Receive News & Ratings for Procter & Gamble Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.